BioGaia

Regulatory Filings • Oct 8, 2009

Press Release 8 October 2009

BioGaia Agreement for Denmark

BioGaia has signed an agreement with the Danish company Pharma Nord Aps, which gives Pharma Nord exclusive rights to sell BioGaia´s Probiotic tablets and drops in Denmark.

Pharma Nord is one of Europe´s largest producers of natural remedies and dietary supplements with sales in a large number of countries. The company has a strong market position in Denmark.

BioGaia´s probiotic products will be sold under the BioGaia brand, marketed towards health professionals with distribution via pharmacies and health food stores. The launch is expected during the first half year 2010.

"Denmark is the only country in Scandinavia where we do not yet sell products and we now look forward to a successful launch built on our strong clinical data", says Peter Rothschild, President BioGaia AB.

Latest press releases from BioGaia:

2009-09-18	BioGaia signs agreement for France
2009-09-17	Personnel changes at BioGaia
2009-08-18	BioGaia AB Interim report 1 January – 30 June 2009

For additional information contact:

Peter Rothschild, Managing Director, telephone: +46 8 -555 293 00 Jan Annwall, Deputy Managing Director, telephone: +46 8-555 293 00

BioGaia is a biotechnology company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has probiotic, health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Small Cap list of the NASDAQ OMX Nordic Exchange Stockholm. www.biogaia.com